Click to watch — the research context on anticholinergic burden, cognitive-wellness markers, and nutrition compounds.
In 2015, a team of researchers at the University of Washington published a paper in JAMA Internal Medicine that became an important part of how clinicians discuss some over-the-counter medications with older adults. The study — a 10-year prospective analysis of 3,434 participants — found that cumulative use of anticholinergic drugs was associated with a higher dementia-risk association. The highest-risk drug category was not a controlled substance or a niche pharmaceutical. It was diphenhydramine: the active ingredient in Benadryl, NyQuil, Advil PM, Tylenol PM, and virtually every OTC sleep aid sold in America.
The paper was published and cited widely, but many patients still benefit from clearer physician-guided conversations about routine OTC use.
To understand why this matters — and why it's been so difficult to communicate — you have to understand what acetylcholine does in the brain, and why long-term exposure questions are best discussed with a qualified healthcare professional.
Acetylcholine is the primary neurotransmitter for memory encoding. When a new experience is being committed to long-term memory, acetylcholine is the chemical signal that opens the synaptic connections required for that process. Anticholinergic medications interact with acetylcholine signaling, which researchers study in relation to memory encoding and cognitive-health markers.
Diphenhydramine was originally developed as an antihistamine and became ubiquitous as a sleep aid because histamine and acetylcholine systems are tightly coupled — blocking one reliably sedates. The problem is that it is a strong anticholinergic compound in common use, with an anticholinergic score of 3 out of 3 on the Anticholinergic Cognitive Burden Scale. The Gray et al. analysis found its consistent use over as few as 3 years associated with higher dementia-risk associations. Yet it is sold without prescription, without age restriction, and with limited consumer-facing discussion of cognitive-risk research.
Second-generation antihistamines were marketed as non-sedating and therefore less sedating. This is more nuanced. While they cross the blood-brain barrier less readily than diphenhydramine, regular use — particularly at the doses people self-escalate to during allergy season — still contributes to cumulative anticholinergic burden. A pharmacological review found that cetirizine at therapeutic doses produced differences on psychomotor speed and divided attention tests in controlled settings, with findings more notable in adults over 60.
Benzodiazepines are not anticholinergic, but they produce a different research pathway: hippocampal-function context. By potentiating GABA-A receptor activity, they influence neural activity — including the hippocampal theta rhythm that is studied in memory encoding and consolidation. A meta-analysis of 7 studies found benzodiazepine users had differences in delayed-recall, attention, and visuospatial measures compared to non-users, with some measures persisting 6 months after discontinuation. In older adults, the combination of a benzodiazepine and a first-generation antihistamine at night — an entirely common pattern — produces an combined anticholinergic and GABAergic context for hippocampal-function research.
What makes this particularly difficult for patients is the latency. A single OTC dose is not the point of the research discussion. The concern studied in older-adult cohorts is cumulative exposure over time, which is why regular use should be reviewed with a healthcare provider rather than changed abruptly based on an article.
The beverage categories referenced in this educational article include:
Pterostilbene is the naturally methylated analog of resveratrol found in highest concentration in blueberries. Unlike resveratrol, pterostilbene has 80% oral bioavailability and a half-life in brain tissue approximately 7 times longer. It accumulates in hippocampal neurons where it stimulates BDNF secretion — the protein that is discussed in relation to BDNF-related pathways and cognitive-wellness research. A study by Chang et al. (2012) in Neurobiology of Aging found pterostilbene reported cognitive-health findings in animal models via BDNF-dependent mechanisms, with differences in working-memory and cognitive-flexibility measures. Human studies on blueberry anthocyanins (the parent compound class) show consistent improvements in word list recall and associative memory in older adults with cognitive-health concerns.
Theobromine is a methylxanthine — structurally related to caffeine but with a longer half-life, lower potency, and no adenosine receptor desensitization. Unlike caffeine, it does not produce cortisol spikes or tolerance escalation. Its research discussion involves vasodilation in cerebral microvasculature — improving blood flow to the hippocampus and frontal cortex — and BDNF stimulation via TrkB receptor pathways. A study in Psychopharmacology found theobromine-containing dark chocolate reported differences in spatial-working-memory and attentional-performance measures. Importantly, theobromine does not antagonize the cholinergic system — making it specifically compatible with the cholinergic research context here.
Acetylcholine is synthesized and released from cholinergic neurons whose membranes are largely composed of monounsaturated fatty acids — particularly oleic acid. Oleic acid is discussed in relation to membrane biology and cognitive-wellness nutrition research. A 6-month RCT by Scott et al. found regular avocado consumption — the most concentrated whole-food source of oleic acid — associated with reported differences in processing-speed and working-memory measures in healthy older adults. The lutein co-occurring in avocado provides additional nutrition context to the hippocampal neurons that pterostilbene and theobromine are supporting.
Pterostilbene, theobromine, and oleic acid are discussed for different nutrition-related roles: BDNF-related pathways, cerebral blood-flow markers, membrane biology, polyphenol intake, and cognitive-wellness research. The video frames these ideas as general bioavailability, food-quality, and routine considerations. Individual needs vary.
// peer-reviewed citations · ingredient context and references · no medical advice implied
// do not discontinue prescription medications without consulting your physician